Noticias y vídeos - 22ND CENTURY GROUP INC. - Inglés

BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously announced warrant inducement offering. During the inducement period, certain holders of the Company’s existing warrants acquired an aggregate of 14,767,386 shares of common stock upon exercise of...

BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of Lawrence (Larry) Firestone as the Company's Chairman and Chief Executive Officer. Nora Sullivan, former Chair of the Board, commented, “Larry is a seasoned executive known for his 'hands-on' leadership style emphasizing...

BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada corporation (the “ Buyer ”), an entity affiliated with current GVB...

BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has again expanded its VLN ® retail presence with more than 500 additional locations across 11 states. With these latest additions, 22nd Century Group’s FDA-authorized VLN ® reduced nicotine content cigarettes can...

BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signing of an additional reduced nicotine content technology license with North Carolina State University. The latest license provides additional modes of efficiently producing reduced nicotine content tobacco plants,...

Third quarter 2023 net revenue of $17.8 million Expanded VLN ® availability to more than 4,550 stores in 19 states Proposed FDA menthol ban regulation now undergoing review at OMB GVB bulk ingredient volume of 49,000 kg shipped Initiated over $15 million in annualized operating cost reductions Reduced principal debt balances by $8.1 million in October 2023 BUFFALO, N.Y., Nov. 06, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on...

BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it supports the recent move by the US Food and Drug Administration to send final rules aimed at banning menthol in cigarettes and banning flavored cigars to the White House Office of Management and Budget for review, a key...

BUFFALO, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it has reduced the outstanding principle of its Senior Secured Credit Facility from approximately $22.1 million to approximately $14.0 million as part of an amendment and waiver process with its lenders. The reduction reflects...

BUFFALO, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the pricing of its previously announced public offering of 10,000,000 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 20,000,000 shares of common stock, at a combined public...

BUFFALO, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it intends to offer and sell in a “best efforts” public offering shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock. All of the shares of common stock...

BUFFALO, N.Y., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced its FDA authorized VLN ® reduced nicotine content cigarettes designed specifically to promote tobacco harm reduction are now available at more than 1,200 drug store locations across Texas, Florida, Illinois, North Carolina...

BUFFALO, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company’s tobacco assets. The process will include consideration of a range of strategic, operational and financial transactions and alternatives, such as business combinations, asset sales, licensing...

Second Quarter 2023 Net Revenues Increased 62% to $23.4 Million Launched VLN ® Sales in California, Texas and Florida Delivered Record GVB Ingredient Volumes as Dominant Supplier in North America Initiated Operating Cost Reduction Program Targeting $15+ Million in Annualized Savings Updated 2023 Revenue Outlook to a Range of $80 Million to $90 Million to Reflect Revised VLN ® Rollout Timelines and Transitioning GVB Ingredient Volumes Back to Internal Production BUFFALO, N.Y., Aug. 14, 2023...

BUFFALO, N.Y., Aug. 09, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at a revised time of 8:00 AM ET to discuss its 2023 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, John Miller, interim chief executive...

BUFFALO, N.Y., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at 10:00 AM ET to discuss its 2023 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, John Miller, interim chief executive officer, and Hugh...

Expands Board with New Highly Accomplished Independent Director Strengthens Balance Sheet and Implements $15 Million Cost Reduction Initiative BUFFALO, N.Y., July 24, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, announced today that John Miller, who leads the tobacco business unit, has been appointed as interim Chief Executive...

BUFFALO, N.Y., July 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced notification that it has regained compliance with Nasdaq listing requirements. In a letter dated July 19, 2023, Nasdaq informed the Company that it has achieved compliance with the minimum bid price rule required for continued...

SACRAMENTO, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Biotech company 22nd Century Group, Inc. (NASDAQ: XXII) this week launched VLN ® King cigarettes, the first-ever reduced nicotine combustible cigarette, in the California market. Starting July 17 th , VLN ® cigarettes contain a staggering 95% less nicotine than conventional cigarettes and will be conveniently available in California at more than 275 sites of the number one convenience store in the US, in addition to numerous other...

Town Pump, #1 Chain in Montana, Selling VLN ® Products in More Than 80 Stores Across the State Broad Availability of VLN ® Expands Access to New Tool to Reduce the Harms of Smoking BUFFALO, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced its VLN ® reduced nicotine content...

BUFFALO, N.Y., July 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced a new distribution agreement with Hub, Inc., a key Midwest based convenience store (C-store) and multi-channel distributor with warehouses located in Missouri and Kansas. 22nd Century’s VLN® products are now available for...